The Restylane portfolio is a non-animal stabilized hyaluronic acid filler with more than 25 years of success and over 50 million treatments worldwide. It is manufactured by Q-Med, a Swedish Galderma company. Galderma is a global pharmaceutical company with over 6,000 employees and a specialization in dermatology, operating in more than 100 countries. Before using Restylane, it is important to be aware of the safety information. People with severe allergies with a history of severe reactions (anaphylaxis), those allergic to lidocaine or gram-positive bacterial proteins used to produce hyaluronic acid, those prone to bleeding, or those with a bleeding disorder should not use Restylane.
Additionally, the safety of its use during pregnancy or breastfeeding has not been studied. People with a history of scarring or pigmentation disorders should also be aware that these side effects can occur with hyaluronic acid fillers. It is also important to tell your doctor if you are taking medications that lower the body's immune response or affect bleeding, such as aspirin or warfarin. These medications may increase the risk of bruising or bleeding at the site of the injection of gel. In addition, use of these products at gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete. The most common side effects associated with Restylane are swelling, redness, pain, bruising, headache, tenderness, lumps, itching at the injection site, and impaired hand function.
However, there are some serious but rare side effects that can occur such as late-onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of an involuntary injection into a blood vessel is small but can occur and cause serious complications such as vision abnormalities, blindness, stroke, temporary crusting, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection. For more information on Restylane and its safety information, sign up for updates and follow us on social media for current news and patient stories.
